US Stock MarketDetailed Quotes

RGEN Repligen

Watchlist
  • 147.550
  • -15.060-9.26%
Close Aug 16 16:00 ET
  • 147.180
  • -0.370-0.25%
Post 20:01 ET
8.26BMarket Cap-7377500P/E (TTM)

About Repligen Company

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Company Profile

SymbolRGEN
Company NameRepligen
Listing DateMay 6, 1986
Founded1981
CEOMr. Tony J. Hunt
MarketNASDAQ
Employees1783
Fiscal Year Ends12-31
Address41 Seyon Street,Building 1, Suite 100
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-781-250-0111
Websitehttp://www.repligen.com

Company Executives

  • Name
  • Position
  • Salary
  • Tony J. Hunt
  • Director and Chief Executive Officer
  • 7.93M
  • Jason K. Garland
  • Chief Financial Officer
  • 2.03M
  • James R. Bylund
  • Chief Operating Officer
  • 3.74M
  • Olivier Loeillot
  • President and Chief Commercial Officer
  • 5.45M
  • Christine Gebski
  • Senior Vice President, Filtration and Chromatography
  • 1.66M
  • Ralf Kuriyel, PhD
  • Senior Vice President, Research and Development
  • 1.66M
  • Dr. Martin D. Madaus,PhD
  • Independent Director
  • 453.50K
  • Dr. Konstantin Konstantinov, PhD
  • Independent Director
  • 282.84K
  • Margaret A. Pax
  • Independent Director
  • --
  • Carrie Eglinton Manner
  • Independent Director
  • 287.84K
  • Nicolas M. Barthelemy
  • Independent Director
  • 307.84K
  • Dr. Rohin Mhatre, PhD
  • Independent Director
  • 287.84K
  • Glenn P. Muir
  • Independent Director
  • 322.84K
  • Karen A. Dawes, M.A.
  • Chairperson of the Board
  • 431.12K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg